- United States
- /
- Medical Equipment
- /
- NasdaqCM:LFWD
ReWalk Robotics Third Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
ReWalk Robotics (NASDAQ:RWLK) Third Quarter 2023 Results
Key Financial Results
- Revenue: US$4.40m (up 397% from 3Q 2022).
- Net loss: US$7.53m (loss widened by 38% from 3Q 2022).
- US$0.13 loss per share (further deteriorated from US$0.087 loss in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
ReWalk Robotics Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 18%.
Looking ahead, revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are up 8.2% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for ReWalk Robotics that you should be aware of before investing here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:LFWD
Lifeward
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
High growth potential with adequate balance sheet.